Zheng Yi-shan, Wu Zong-sheng, Zhang Lu-yao, Ke Lu, Li Wei-qin, Li Ning, Li Jie-shou
From the *Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University; and †Intensive Care Unit, Second Affiliated Hospital of Southeast University, Nanjing, Jiangsu, China.
Pancreas. 2015 Apr;44(3):500-6. doi: 10.1097/MPA.0000000000000294.
OBJECTIVES: Activation of "nicotinic anti-inflammatory pathway" could reduce severity of inflammation and injury induced by acute pancreatitis. However, the role of regulatory T (Treg) cells in this pathway is unclear. METHODS: Severe acute pancreatitis (SAP) was induced in mice through retrograde injection of 50-μL 2% Na-taurocholate into the pancreatic duct of the mouse. In nicotine treatment group, nicotine (50, 100, and 300 μg/kg) was administered 1 hour before and after SAP operation through intraperitoneal injection. We compared the properties of Treg cell percentage and specific marker such as cytotoxic T-lymphocyte antigen 4 and forkhead box transcription factor forkhead/winged helix transcription factor p3 on Treg using quantitative reverse transcription polymerase chain reaction and flow cytometry. All experiment animal serum cytokines were measured using enzyme-linked immunosorbent assay. One-way analysis of variance was applied to evaluate the experimental data and for statistical comparisons. The survival rate data were analyzed using the log-rank test. RESULTS: Nicotine significantly protected mice from lethal SAP in a dose-dependent fashion by inhibiting tissue injury, digestive enzyme production, and proinflammatory cytokines production. Moreover, nicotine up-regulated the number and suppressive capacity of CD4 CD25 Treg via inducing the expression of immunoregulatory molecules and transforming growth factor β1 elevation. CONCLUSIONS: Modulating immunoregulation of CD4 CD25 Treg is a critical mechanism for nicotinic anti-inflammatory pathway and it may be feasible to use selective agonists as an immunotherapy for SAP.
World J Gastroenterol. 2015-4-21
J Gastroenterol Hepatol. 2007-11
Int J Clin Exp Pathol. 2013-11-15
Immun Inflamm Dis. 2024-7
Am J Physiol Gastrointest Liver Physiol. 2022-11-1
Front Cell Infect Microbiol. 2020-3-31